Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
溶瘤病毒疗法诱导的CSDE1新抗原生成会限制VSV复制,但可通过免疫疗法进行靶向治疗。
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-021-22115-1
Timothy Kottke ,Jason Tonne ,Laura Evgin ,Christopher B Driscoll ,Jacob van Vloten ,Victoria A Jennings ,Amanda L Huff ,Brady Zell ,Jill M Thompson ,Phonphimon Wongthida ,Jose Pulido ,Matthew R Schuelke ,Adel Samson ,Peter Selby ,Elizabeth Ilett ,Mark McNiven ,Lewis R Roberts ,Mitesh J Borad ,Hardev Pandha ,Kevin Harrington ,Alan Melcher ,Richard G Vile